A DC-based mRNA vaccine encoding CD40Ligand, CD70, and TLR4 (TriMixDC), and transfected with melanoma associated genes (MAGE, Tyrosinase, gp100-TriMix-MEL) was evaluated in a cohort of advanced melanoma patients. Here, TYR is linked to melanoma.